Clinical trials
Active, not recruiting Phase 1 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
266 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 7 |
| 2020 | 7 |
| 2021 | 23 |
| 2022 | 41 |
| 2023 | 33 |
| 2024 | 50 |
| 2025 | 67 |
| 2026 | 35 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 266 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sichuan Baili Pharmaceutical Co., Ltd. | 8 |
| Jiangsu HengRui Medicine Co., Ltd. | 7 |
| Novartis Pharmaceuticals | 7 |
| Innovent Biologics (Suzhou) Co. Ltd. | 6 |
| Janssen Research & Development, LLC | 6 |
| West China Hospital | 5 |
| Institute of Hematology & Blood Diseases Hospital, China | 4 |
| Shanghai Changzheng Hospital | 4 |
| Shanghai Junshi Bioscience Co., Ltd. | 4 |
| AbbVie | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 22 |
| Breast Neoplasms | 13 |
| Neoplasms | 13 |
| Colorectal Neoplasms | 12 |
| Neoplasm Metastasis | 10 |
| Carcinoma, Renal Cell | 8 |
| Recurrence | 8 |
| Lymphoma, Non-Hodgkin | 7 |
| Melanoma | 7 |
| Prostatic Neoplasms | 7 |
Trials
Showing 1 to 25 of 266. Each trial links to its page on Pharma Observatory.
166 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.